首页 > 市场调查报告书 > 製药

DDS 疼痛

市场调查报告书

商品编码

1498658

全球非鸦片类止痛贴市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Non-Opioid Pain Patches Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球非鸦片类止痛贴市场需求预计将从 2023 年的 5.0824 亿美元达到近 7.4688 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 4.37%。

非鸦片类止痛贴片是一种透皮治疗系统，旨在在不使用鸦片类药物的情况下缓解疼痛。这些贴片通常含有缓解局部疼痛的活性成分，如利多卡因、辣椒素或 NSAID（非类固醇抗发炎药）。它们用于治疗各种类型的疼痛，包括慢性疼痛、神经性疼痛和手术后疼痛。将贴片直接贴在疼痛部位的皮肤上，使药物随着时间的推移而稳定地吸收。它提供了阿片类药物的更安全替代品，降低了与阿片类药物使用相关的成瘾风险和副作用。

市场动态

人们对鸦片类止痛药的副作用和成瘾潜力的认识不断提高，刺激了对非鸦片类药物替代品的需求，导致止痛贴的使用量激增。这些贴片透过透皮给药系统提供局部疼痛缓解，最大限度地减少与口服药物相关的全身性副作用，同时有针对性地缓解特定区域的不适。贴片配方和递送机制的技术进步提高了非鸦片类止痛贴片的功效和便利性，使其越来越受到医疗保健专业人员和患者的青睐。缓释製剂、新型药物组合和改进的黏合性能等创新有助于更好的疼痛管理结果和患者依从性。此外，人口老化的不断扩大，加上关节炎、神经病变和肌肉骨骼疾病等慢性疼痛疾病的发病率不断上升，刺激了市场对非阿片类止痛贴片的需求，将其作为长期疼痛管理的安全有效的替代品。

此外，旨在遏制阿片类药物滥用和推广非药物疼痛管理策略的监管倡议鼓励医疗保健提供者开出止痛贴等非阿片类药物替代品，进一步促进市场成长。此外，疼痛贴片的便利性和谨慎性使患者能够灵活地进行疼痛缓解治疗，而无需频繁给药或侵入性操作，从而提高他们的生活品质并促进疼痛症状的自我管理。然而，高昂的成本和有限的保险覆盖范围可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球非鸦片类止痛贴片市场的每个细分市场进行了包容性评估。非阿片类止痛贴产业的成长和趋势为本研究提供了整体方法。

市场区隔

非阿片类止痛贴市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按类型

利多卡因贴剂
双氯芬酸贴剂
水杨酸甲酯贴片
辣椒素贴片
酮洛芬贴剂
其他的

按配销通路

医院药房
网路药局
药局
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲非鸦片类止痛贴片市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。非鸦片类止痛贴片市场的主要参与者包括辉瑞公司、Mylan NV、葛兰素史克公司、艾尔建、久光製药有限公司、德成製药有限公司、Acorda Therapeutics Ltd.、Teikoku Seiyaku Co. Ltd. 。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：非鸦片类止痛贴片公司的竞争格局

非阿片类止痛贴市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Pfizer Inc.

公司简介
公司收入
产品
最近的发展

Mylan NV

公司简介
公司收入
产品
最近的发展

GlaxoSmithKline Plc

公司简介
公司收入
产品
最近的发展

Allergan

公司简介
公司收入
产品
最近的发展

Hisamitsu Pharmaceutical Co. Inc.

公司简介
公司收入
产品
最近的发展

Teh Seng Pharmaceutical Mfg. Co.

公司简介
公司收入
产品
最近的发展

Acorda Therapeutics Ltd.

公司简介
公司收入
产品
最近的发展

Teikoku Seiyaku Co. Ltd.

公司简介
公司收入
产品
最近的发展

IBSA Institut Biochimque SA Inc

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114766

The global demand for Non-Opioid Pain Patches Market is presumed to reach the market size of nearly USD 746.88 Million by 2032 from USD 508.24 Million in 2023 with a CAGR of 4.37% under the study period 2024-2032.

Non-opioid pain patches are transdermal therapeutic systems designed to deliver pain relief without the use of opioids. These patches generally comprise active ingredients such as lidocaine, capsaicin, or NSAIDs (nonsteroidal anti-inflammatory drugs) that relieve localized pain. They are used to treat various types of pain, including chronic pain, neuropathic pain, and post-surgical pain. The patch is directly applied to the skin over the painful area, allowing the medication to be absorbed steadily over time. It offers a safer alternative to opioid medications, lowering the risk of addiction & side effects associated with opioid use.

MARKET DYNAMICS

Rising awareness about the adverse effects and addictive potential of opioid-based pain medications has spurred the demand for non-opioid alternatives, leading to a surge in the adoption of pain patches. These patches offer localized pain relief through transdermal drug delivery systems, minimizing systemic side effects associated with oral medications while providing targeted relief to specific areas of discomfort. Technological advancements in patch formulations and delivery mechanisms have enhanced the efficacy and convenience of non-opioid pain patches, making them increasingly preferred among healthcare professionals and patients. Innovations such as extended-release formulations, novel drug combinations, and improved adhesive properties contribute to better pain management outcomes and patient compliance. Moreover, the expanding aging population, together with the spurring incidence of chronic pain conditions such as arthritis, neuropathy, and musculoskeletal disorders, fuels market demand for non-opioid pain patches as a safe and effective alternative for long-term pain management.

Additionally, regulatory initiatives aimed at curbing opioid misuse and promoting non-pharmacological pain management strategies further bolster market growth by encouraging healthcare providers to prescribe non-opioid alternatives like pain patches. Furthermore, the convenience and discreet nature of pain patches offer patients the flexibility to administer pain relief therapy without frequent dosing or invasive procedures, enhancing their quality of life and promoting self-management of pain symptoms. However, high costs and limited insurance coverage may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Non-Opioid Pain Patches. The growth and trends of Non-Opioid Pain Patches industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Non-Opioid Pain Patches market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others

By Distribution Channel

Hospitals Pharmacies
Online Pharmacies
Drug Stores
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Non-Opioid Pain Patches market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Non-Opioid Pain Patches market include Pfizer Inc., Mylan N.V., GlaxoSmithKline Plc, Allergan, Hisamitsu Pharmaceutical Co. Inc., Teh Seng Pharmaceutical Mfg. Co., Acorda Therapeutics Ltd., Teikoku Seiyaku Co. Ltd., IBSA Institut Biochimque SA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NON-OPIOID PAIN PATCHES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Lidocaine Patches Historic and Forecast Sales By Regions
5.4. Diclofenac Patches Historic and Forecast Sales By Regions
5.5. Methyl Salicylate Patches Historic and Forecast Sales By Regions
5.6. Capsaicin Patches Historic and Forecast Sales By Regions
5.7. Ketoprofen Patches Historic and Forecast Sales By Regions
5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospitals Pharmacies Historic and Forecast Sales By Regions
6.4. Online Pharmacies Historic and Forecast Sales By Regions
6.5. Drug Stores Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL NON-OPIOID PAIN PATCHES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE NON-OPIOID PAIN PATCHES COMPANIES

8.1. Non-Opioid Pain Patches Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF NON-OPIOID PAIN PATCHES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Pfizer Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Mylan N.V.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. GlaxoSmithKline Plc
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Allergan
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Hisamitsu Pharmaceutical Co. Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Teh Seng Pharmaceutical Mfg. Co.
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Acorda Therapeutics Ltd.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Teikoku Seiyaku Co. Ltd.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. IBSA Institut Biochimque SA Inc
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments